Literature DB >> 31485847

NK and NKT-like cells in granulomatous and fibrotic lung diseases.

L Bergantini1, P Cameli2, M d'Alessandro2, C Vagaggini2, R M Refini2, C Landi3, M G Pieroni2, M Spalletti2, P Sestini2, E Bargagli2.   

Abstract

ABTRACT: Background The pathogenetic and regulatory roles of natural killer (NK) and natural killer T-like cells in interstitial lung diseases (ILDs), fibrotic and granulomatous of unknown etiology are unclear. Objectives Here we investigated NK and NKT-like cells in peripheral blood (PB) and Bronchoalveolar lavage (BAL) from patients with ILDs. Method 190 patients (94 male mean age 61 ± 14.3 years) and 8 controls undergoing bronchoscopy for ILD diagnostic work-up were enrolled consecutively; 115 patients sarcoidosis, 24 chronic fibrotic hypersensitivity pneumonitis and 43 patients other ILDs [32 idiopathic pulmonary fibrosis (IPF) and 11 non-specific interstitial pneumonia (NSIP)]. PB and BAL were processed by flow cytometry using monoclonal antibodies to differentiate NK and NKT-like cells. Results NK% in BAL was significantly different among ILDs (p = 0.02). Lower NK% was observed in BAL from sarcoidosis than other ILDs (p < 0.05). Similar findings were observed for NKT-like, whereas no differences were found for PB NK%. Difference of NK% was observed between BAL and PB in all groups (p < 0.001). Sarcoidosis patients reported the best area under the curve for NKT-like (AUC = 0.678, p = 0.0015) and NK cells (AUC = 0.61, p = 0.001). In the IPF-NSIP subgroup, NK% cell was inversely correlated with FVC% (r = - 0.34, p = 0.03) and DLCO% (r = - 0.47, p = 0.0044). Conclusions NK and NKT-like were expressed differently in BAL from patients with different ILD and were significantly depleted in sarcoidosis respect to other ILDs. This suggests that these cells may play a protective role in the pathogenesis of sarcoidosis.

Entities:  

Keywords:  Bronchoalveolar lavage; Interstitial lung diseases; Natural killer T-like cells; Natural killer cells

Mesh:

Year:  2019        PMID: 31485847     DOI: 10.1007/s10238-019-00578-3

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  40 in total

Review 1.  Immunometabolism and natural killer cell responses.

Authors:  Katie L O'Brien; David K Finlay
Journal:  Nat Rev Immunol       Date:  2019-05       Impact factor: 53.106

Review 2.  Hypersensitivity pneumonitis: Antigen diversity and disease implications.

Authors:  R Nogueira; N Melo; H Novais E Bastos; N Martins; L Delgado; A Morais; P C Mota
Journal:  Pulmonology       Date:  2018-08-17

3.  Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.

Authors:  Nicole S Goh; Rachel K Hoyles; Christopher P Denton; David M Hansell; Elisabetta A Renzoni; Toby M Maher; Andrew G Nicholson; Athol U Wells
Journal:  Arthritis Rheumatol       Date:  2017-07-18       Impact factor: 10.995

4.  Direct antiviral agents upregulate natural killer cell potential activity in chronic hepatitis C patients.

Authors:  Han-Ji Jiang; Xiao-Xiao Wang; Bi-Fen Luo; Xu Cong; Qian Jin; Hong Qin; Hai-Ying Zhang; Xiang-Sha Kong; Lai Wei; Bo Feng
Journal:  Clin Exp Med       Date:  2019-06-20       Impact factor: 3.984

5.  Interleukins 15 and 12 in combination expand the selective loss of natural killer T cells in HIV infection in vitro.

Authors:  Venkata Ramanarao Parasa; Anbalagan Selvaraj; Rajasekaran Sikhamani; Alamelu Raja
Journal:  Clin Exp Med       Date:  2014-04-20       Impact factor: 3.984

6.  Hypersensitivity pneumonitis secondary to residential exposure to Aureobasidium pullulans in 2 siblings.

Authors:  James Temprano; Bradley A Becker; Patricia S Hutcheson; Alan P Knutsen; Anupma Dixit; Raymond G Slavin
Journal:  Ann Allergy Asthma Immunol       Date:  2007-12       Impact factor: 6.347

7.  Induction of antiinflammatory purinergic signaling in activated human iNKT cells.

Authors:  Jennifer C Yu; Gene Lin; Joshua J Field; Joel Linden
Journal:  JCI Insight       Date:  2018-09-06

Review 8.  Innate lymphoid cell memory.

Authors:  Xianwei Wang; Hui Peng; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2019-02-22       Impact factor: 11.530

Review 9.  Therapeutic Targeting Steroid Resistant Pro-Inflammatory NK and NKT-Like Cells in Chronic Inflammatory Lung Disease.

Authors:  Greg Hodge; Sandra Hodge
Journal:  Int J Mol Sci       Date:  2019-03-26       Impact factor: 5.923

10.  Immune Cell Composition in Human Non-small Cell Lung Cancer.

Authors:  Branislava Stankovic; Heidi Anine Korsmo Bjørhovde; Renate Skarshaug; Henrik Aamodt; Astri Frafjord; Elisabeth Müller; Clara Hammarström; Kahsai Beraki; Espen S Bækkevold; Per Reidar Woldbæk; Åslaug Helland; Odd Terje Brustugun; Inger Øynebråten; Alexandre Corthay
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

View more
  16 in total

1.  Immune-Checkpoint Expression on CD4, CD8 and NK Cells in Blood, Bronchoalveolar Lavage and Lymph Nodes of Sarcoidosis.

Authors:  Miriana d'Alessandro; Laura Bergantini; Fabrizio Mezzasalma; Dalila Cavallaro; Sara Gangi; Stefano Baglioni; Martina Armati; Marta Abbritti; Stefano Cattelan; Paolo Cameli; Elena Bargagli
Journal:  Mol Diagn Ther       Date:  2022-06-27       Impact factor: 4.476

2.  BAL biomarkers' panel for differential diagnosis of interstitial lung diseases.

Authors:  Miriana d'Alessandro; Alfonso Carleo; Paolo Cameli; Laura Bergantini; Anna Perrone; Lucia Vietri; Nicola Lanzarone; Cecilia Vagaggini; Piersante Sestini; Elena Bargagli
Journal:  Clin Exp Med       Date:  2020-01-22       Impact factor: 3.984

3.  Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy.

Authors:  Miriana d'Alessandro; Laura Bergantini; Paolo Cameli; Maria Pieroni; Rosa Metella Refini; Piersante Sestini; Elena Bargagli
Journal:  Cancers (Basel)       Date:  2021-02-09       Impact factor: 6.639

Review 4.  Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects.

Authors:  Raisa Kraaijvanger; Montse Janssen Bonás; Adriane D M Vorselaars; Marcel Veltkamp
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

Review 5.  T Cells in Fibrosis and Fibrotic Diseases.

Authors:  Mengjuan Zhang; Song Zhang
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

6.  Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases.

Authors:  Laura Bergantini; Miriana d'Alessandro; Lucia Vietri; Giuseppe Domenico Rana; Paolo Cameli; Silvia Acerra; Piersante Sestini; Elena Bargagli
Journal:  Immunol Res       Date:  2020-10-22       Impact factor: 2.829

Review 7.  Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis.

Authors:  Elena Bargagli; Rosa Metella Refini; Miriana d'Alessandro; Laura Bergantini; Paolo Cameli; Lorenza Vantaggiato; Luca Bini; Claudia Landi
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

8.  Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis.

Authors:  Susanna Kullberg; Natalia V Rivera; Johan Grunewald; Anders Eklund
Journal:  BMJ Open Respir Res       Date:  2021-07

9.  Clinical phenotyping in sarcoidosis management.

Authors:  Giuseppe Domenico Rana; Miriana d'Alessandro; Luigi Rizzi; Laura Bergantini; Paolo Cameli; Alfredo Vozza; Piersante Sestini; Patrizia Suppressa; Elena Bargagli
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-06-28       Impact factor: 0.670

10.  Adaptive immune system in pulmonary sarcoidosis-Comparison of peripheral and alveolar biomarkers.

Authors:  Miriana d'Alessandro; Laura Bergantini; Paolo Cameli; Fabrizio Mezzasalma; Rosa Metella Refini; Maria Pieroni; Piersante Sestini; Elena Bargagli
Journal:  Clin Exp Immunol       Date:  2021-07-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.